Newsroom
Company news
Business
22 September 2020
Alvotech and DKSH extend partnership in Asia
Alvotech and DKSH, a leading healthcare provider across 36 emerging countries in South-East Asia, today announced an expansion of their strategic partnership to commercialize six new biosimilar product candidates for the Asian markets.
Business
05 August 2020
Alvotech and Teva announce strategic partnership to collaborate in the U.S. biosimilar market
People
18 May 2020
Tanya Zharov joins Alvotech as Deputy CEO
Business
12 May 2020
Alvotech announces positive top-line results for two comparative studies for AVT02, a proposed biosimilar to HUMIRA® (adalimumab)
Business
05 May 2020
Alvotech and Alvogen launch new B2B business brand
Business
24 March 2020
Delivering on our promise during the Coronavirus Pandemic
Business
24 March 2020
Alvotech and DKSH partner to bring key biosimilar to Asia
Business
14 January 2020
Alvotech and JAMP Pharma enter into an exclusive partnership for the commercialization of key biosimilars in Canada
Business
13 November 2019
Alvotech at CPhI 2019
Business
06 November 2019
Alvotech and Stada agree on strategic biosimilar partnership
Business
04 November 2019
Yas Holding invests in Alvotech and agrees on a strategic partnership for biosimilar candidates
People
30 September 2019
Alvotech appoints new Chief Scientific Officer
Business
13 September 2019
Alvotech is warming up for CPhI 2019 in Frankfurt
Business
27 August 2019
Alvotech and Prestige Biopharma announce new manufacturing partnership
Business
29 July 2019
Alvotech and Cipla gulf into a partnership
Business
15 July 2019
Alvotech completes enrollment of phase III study involving biosimilar version of Humira®
Business
03 June 2019
Alvotech and Abdi Ibrahim enter into an exclusive partnership
People
09 May 2019
Mark Levick appointed CEO of Alvotech
Business
09 April 2019